4-(hex-5-yn-1-yl)morpholine | 320366-85-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 恶嗪烷类
• 英文名称: 4-(hex-5-yn-1-yl)morpholine
• 英文别名: N-(hex-5-yn-1-yl)morpholine；6-morpholino-1-hexyne；4-hex-5-ynylmorpholine
• CAS: 320366-85-6
• 化学式: C₁₀H₁₇NO
• 分子量: 167.251
• InChiKey: ZHEFLYSERANXJR-UHFFFAOYSA-N

物化性质

• 沸点：
  242.9±25.0 °C(Predicted)
• 密度：
  0.950±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  12.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-(hex-5-yn-1-yl)morpholine 在 1-hydroxytetraphenylcyclopentadienyl(tetraphenyl-2,4-cyclopentadien-1-one)-μ-hydrotetracarbonyldiruthenium(II) 、 Au(IPr)Cl 、 水 、 silver trifluoroacetate 、 对甲苯磺酸 作用下， 以 异丙醇 为溶剂， 反应 48.0h， 以75%的产率得到6-morpholinohexan-2-ol
  参考文献：
  名称：

  Regioselective Reductive Hydration of Alkynes To Form Branched or Linear Alcohols

  摘要：

  The regioselective reductive hydration of terminal alkynes using two complementary dual catalytic systems is described. Branched or linear alcohols are obtained in 75-96% yield with >= 25:1 regioselectivity from the same starting materials. The method is compatible with terminal, di-, and trisubstituted alkenes. This reductive hydration constitutes a strategic surrogate to alkene oxyfunctionalization and may be of utility in multistep settings.

  DOI：

  10.1021/ja307145e
• 作为产物：
  描述：

  吗啉 、 甲磺酸己-5-炔基酯 在 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 5.0h， 以53%的产率得到4-(hex-5-yn-1-yl)morpholine
  参考文献：
  名称：

  铑（I）催化α，β-不饱和亚胺与末端炔烃的[4 + 1]环加成反应，用于制备吡咯衍生物

  摘要：

  亚乙烯基铑中间体是标题反应的特征（参见方案； coe ＝环辛烯，cy ＝环己基）。该反应通过将亚胺的氮原子亲核加成到亚乙烯基铑配合物中而得到两性离子中间体，该两性离子中间体经过分子内环化得到相应的吡咯。

  DOI：

  10.1002/anie.200904402

文献信息

• Cross-Coupling of Nonactivated Alkyl Halides with Alkynyl Grignard Reagents: A Nickel Pincer Complex as the Catalyst
  作者：Oleg Vechorkin、Aurélien Godinat、Rosario Scopelliti、Xile Hu

  DOI：10.1002/anie.201105964

  日期：2011.12.2

  In a pinch: The nickel pincer complex 1 catalyzes the cross‐coupling of the title compounds with remarkable substrate scope and functional group tolerance. A nickel/alkynyl species was isolated and shown to be catalytically competent. THF=tetrahydrofuran, O‐TMEDA=bis[2‐(N,N‐dimethylaminoethyl)] ether.

  紧要关头：镍钳配合物1催化标题化合物的交叉偶联，具有显着的底物范围和官能团耐受性。分离出镍/炔基物质，并显示出催化能力。THF =四氢呋喃，O-TMEDA =双[2-（N，N-二甲基氨基乙基）]醚。
• Therapy
  申请人：——

  公开号：US20030225111A1

  公开（公告）日：2003-12-04

  The invention concerns the use of a quinazoline derivative of Formula (I) wherein Q 1 includes a quinazoline ring optionally substituted with a group such as halogeno, trifluoromethyl and cyano, or a group of the formula: Q 3 —X 1 — wherein X 1 includes a direct bond and O and Q 3 includes aryl, aryl-(1-6C)alkyl, heterocyclyl and heterocyclyl-(1-6C)alkyl; each of R 2 and R 3 is hydrogen or (1-6C)alkyl; Z includes O, S and NH; and Q 2 includes aryl and aryl-(1-3C)alkyl or a pharmaceutically-acceptable salt thereof, in the manufacture of a medicament for use in the production of an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal such as a human. 1

  该发明涉及使用式（I）的喹唑啉衍生物，其中Q1包括一个喹唑啉环，可选地取代为卤、三氟甲基和氰等基团，或者具有式Q3-X1-的基团，其中X1包括直接键和O，Q3包括芳基、芳基-(1-6C)烷基、杂环基和杂环基-(1-6C)烷基；R2和R3中的每一个是氢或(1-6C)烷基；Z包括O、S和NH；Q2包括芳基和芳基-(1-3C)烷基或其药用可接受盐，在制备药物时用于在温血动物（如人类）中产生抗血管生成和/或降低血管通透性的效果。
• Quinazoline derivatives
  申请人：AstraZeneca UK Limited

  公开号：US06806274B1

  公开（公告）日：2004-10-19

  The invention concerns quinazoline derivatives of Formula (I) wherein Q1 includes a quinazoline ring optionally substituted with a group such as halogeno, trifluoromethyl and cyano, or a group of the formula: Q3—X1— wherein X1 includes a direct bond and O and Q3 includes aryl, aryl-(1-6C)alkyl, heterocyclyl and heterocyclyl-(1-6C)alkyl; each of R2 and R3 is hydrogen or (1-6C)alkyl; Z includes O, S and NH; and Q2 includes aryl and aryl-(1-3C)alkyl or a pharmaceutically-acceptable salt thereof; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the prevention or treatment of T cell mediated diseases or medical conditions in a warm-blooded animal.

  该发明涉及式(I)的喹唑啉衍生物，其中Q1包括一个喹唑啉环，可选择地取代为卤素、三氟甲基和氰基等基团，或者具有以下式的基团：Q3—X1—，其中X1包括直接键和O，Q3包括芳基、芳基-(1-6C)烷基、杂环基和杂环基-(1-6C)烷基；R2和R3中的每一个是氢或(1-6C)烷基；Z包括O、S和NH；Q2包括芳基和芳基-(1-3C)烷基或其药用可接受盐；它们的制备方法，含有它们的药物组合物以及它们在制造用于预防或治疗温血动物T细胞介导疾病或医疗状况的药物中的用途。
• Broad-Spectrum Catalysts for the Ambient Temperature Anti-Markovnikov Hydration of Alkynes
  作者：Le Li、Mingshuo Zeng、Seth B. Herzon

  DOI：10.1002/anie.201404320

  日期：2014.7.21

  Anti‐Markovnikov alkyne hydration provides a valuable route to aldehydes. Half‐sandwich ruthenium complexes ligated by 5,5′‐bis(trifluoromethyl)‐2,2′‐bipyridine are remarkably active for this transformation. In the presence of 2 mol % metal, a wide range of functionalized aliphatic and aromatic alkynes are hydrated in high yield at ambient temperature.

  抗马尔科夫尼科夫炔烃水合为醛的合成提供了有价值的途径。由5,5'-双（三氟甲基）-2,2'-联吡啶连接的半三明治钌络合物对于该转化非常有效。在2mol％金属的存在下，在环境温度下高产率地将多种官能化的脂族和芳族炔烃水合。
• Temporal separation of catalytic activities allows anti-Markovnikov reductive functionalization of terminal alkynes
  作者：Le Li、Seth B. Herzon

  DOI：10.1038/nchem.1799

  日期：2014.1

  There is currently great interest in the development of multistep catalytic processes in which one or several catalysts act sequentially to rapidly build complex molecular structures. Many enzymes—often the inspiration for new synthetic transformations—are capable of processing a single substrate through a chain of discrete, mechanistically distinct catalytic steps. Here, we describe an approach to emulate the efficiency of these natural reaction cascades within a synthetic catalyst by the temporal separation of catalytic activities. In this approach, a single catalyst exhibits multiple catalytic activities sequentially, allowing for the efficient processing of a substrate through a cascade pathway. Application of this design strategy has led to the development of a method to effect the anti-Markovnikov (linear-selective) reductive functionalization of terminal alkynes. The strategy of temporal separation may facilitate the development of other efficient synthetic reaction cascades. Multifunctional catalysts typically process substrates and intermediates concurrently. Here, a strategy is described to separate catalytic activities in the time domain (temporal separation). Application of this strategy has led to the development of a method to effect the anti-Markovnikov reductive functionalization of terminal alkynes; such an approach may facilitate the development of other synthetic reaction cascades.

  目前，发展多步催化过程备受关注，其中一个或多个催化剂按顺序作用，以快速构建复杂分子结构。许多酶——通常是新合成转化的灵感来源——能够通过一系列离散的、机制上不同的催化步骤处理单一底物。在这里，我们描述了一种通过催化活性的时间分离来模拟这些自然反应级联的效率的方法。在这种方法中，单一催化剂按顺序展现多种催化活性，从而允许有效地通过级联路径处理底物。该设计策略的应用促成了一种方法，以实现末端炔烃的反马尔科夫尼科夫（线性选择性）还原官能化。时间分离的策略可能会促进其他高效合成反应级联的发展。多功能催化剂通常同时处理底物和中间体。在这里，描述了一种在时间领域分离催化活性的策略（时间分离）。该策略的应用促成了一种方法，以实现末端炔烃的反马尔科夫尼科夫还原官能化；如此方法可能会促进其他合成反应级联的发展。